PubMed: 22102280

Title
Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib.
Journal
The Journal of biological chemistry
Volume
287
Issue
None
Pages
893-904
Date
2012-01-06
Authors
Delgado E | Domínguez JM | Fuertes A | Medina M | Orozco L | del Monte-Millán M

Evidence 71a06e3916

Alsterpaullone showed identical results with the wild-type and the mutant enzymes, demonstrating that its mechanism of inhibition is independent of the presence of the Cys-199 residue.

Evidence 935ba128cd

Inhibition caused by hypothemycin and tideglusib on a panel of selected human recombinant kinases

Evidence cdc281a59b

We report here that tideglusib inhibits GSK-3β irreversibly, as demonstrated by the lack of recovery in enzyme function after the unbound drug has been removed from the reaction medium and the fact that its dissociation rate constant is non-significantly different from zero.

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.